| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Division of Endocrinology (A.C.K., B.H., M.T.A.N.), Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital and Lady Davis Institute for Medical Research, McGill University, Montréal, Canada H3T 1E2; Department of Clinical Genetics (I.D.Y.), City Hospital, Nottingham, United Kingdom; Department of Histopathology, Derbyshire Royal Infirmary, NHS Trust, Derby, United Kingdom (D.S.); and 1st Department of Oral Anatomy (H.O., N.A.), Nigata University School of Dentistry, Niigata, Japan
Address all correspondence and requests for reprints to: Andrew C. Karaplis, M.D., Ph.D., McGill University, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Research Institute, Room 626 3755 Cote Ste Catherine Road, Montréal, H3T 1E2, Canada.
A single homozygous nucleotide exchange in exon E3 of the gene encoding the parathyroid hormone receptor type 1 (PTHR1) was identified in an infant with Blomstrand chondrodysplasia born to consanguineous parents. This alteration changes a strictly conserved proline residue at position 132 in the receptors amino terminal extracellular domain to leucine. COS-1 cells expressing the mutant receptor did not accumulate cyclic adenosine 3',5'-monophosphate in response to PTH or PTH-related peptide (PTHrP) and did not bind the radiolabeled ligand. Expression of the mutant protein on the cell surface of transiently transfected COS-1 cells and in growth plate chondrocytes derived from the affected infant suggests that proline 132 is critical for the receptors intrinsic binding activity. These findings suggest that the Blomstrand form of human short-limbed dwarfism arises from defective PTHR1 signaling in the developing cartilaginous skeleton.
This article has been cited by other articles:
![]() |
D. Panda, D. Goltzman, H. Juppner, and A. C. Karaplis TIP39/parathyroid hormone type 2 receptor signaling is a potent inhibitor of chondrocyte proliferation and differentiation Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1125 - E1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Couvineau, V. Wouters, G. Bertrand, C. Rouyer, B. Gerard, L. M. Boon, B. Grandchamp, M. Vikkula, and C. Silve PTHR1 mutations associated with Ollier disease result in receptor loss of function Hum. Mol. Genet., September 15, 2008; 17(18): 2766 - 2775. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gupta, V.-V. Valimaki, M. J Valimaki, E. Loyttyniemi, M. Richard, P. L Bukka, D. Goltzman, and A. C Karaplis Variable number of tandem repeats polymorphism in parathyroid hormone-related protein as predictor of peak bone mass in young healthy Finnish males Eur. J. Endocrinol., May 1, 2008; 158(5): 755 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Parthier, M. Kleinschmidt, P. Neumann, R. Rudolph, S. Manhart, D. Schlenzig, J. Fanghanel, J.-U. Rahfeld, H.-U. Demuth, and M. T. Stubbs Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor PNAS, August 28, 2007; 104(35): 13942 - 13947. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Ruiz-Perez, H. J. Blair, M. E. Rodriguez-Andres, M. J. Blanco, A. Wilson, Y.-N. Liu, C. Miles, H. Peters, and J. A. Goodship Evc is a positive mediator of Ihh-regulated bone growth that localises at the base of chondrocyte cilia Development, August 15, 2007; 134(16): 2903 - 2912. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hoogendam, H. Farih-Sips, L. C. Wynaendts, C. W. G. M. Lowik, J. M. Wit, and M. Karperien Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1088 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Kronenberg How PTHrP Controls Growth Plate Chondrocytes IBMS BoneKEy, November 1, 2005; 2(11): 7 - 15. [Full Text] [PDF] |
||||
![]() |
E. Maioli, V. Fortino, and A. Pacini Parathyroid Hormone-Related Protein in Preeclampsia: A Linkage Between Maternal and Fetal Failures Biol Reprod, December 1, 2004; 71(6): 1779 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Miao, B. He, B. Lanske, X.-Y. Bai, X.-K. Tong, G. N. Hendy, D. Goltzman, and A. C. Karaplis Skeletal Abnormalities in Pth-Null Mice Are Influenced by Dietary Calcium Endocrinology, April 1, 2004; 145(4): 2046 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wang, A. Woods, S. Sabari, L. Pagnotta, L.-A. Stanton, and F. Beier RhoA/ROCK Signaling Suppresses Hypertrophic Chondrocyte Differentiation J. Biol. Chem., March 26, 2004; 279(13): 13205 - 13214. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Qian, M. C. Colbert, D. Witte, C.-Y. Kuan, E. Gruenstein, H. Osinska, B. Lanske, H. M. Kronenberg, and T. L. Clemens Midgestational Lethality in Mice Lacking the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Is Associated with Abrupt Cardiomyocyte Death Endocrinology, March 1, 2003; 144(3): 1053 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Clemens, J. Qian, and M. C. Colbert Editorial: Prenatal Lethality in PTH Type I Receptor Null Mice--Interrogating the Usual Suspects Endocrinology, December 1, 2001; 142(12): 5056 - 5058. [Full Text] [PDF] |
||||
![]() |
D. W. Soegiarto, S. Kiachopoulos, E. Schipani, H. Juppner, R. G. Erben, and B. Lanske Partial Rescue of PTH/PTHrP Receptor Knockout Mice by Targeted Expression of the Jansen Transgene Endocrinology, December 1, 2001; 142(12): 5303 - 5310. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Lee, T. J. Kotlar, I. Ciric, M. K. Lee, S. K. Lim, H. C. Lee, K. B. Huh, K. E. Mayo, and J. L. Jameson Absence of Constitutively Activating Mutations in the GHRH Receptor in GH-Producing Pituitary Tumors J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3989 - 3995. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Wysolmerski, S. Cormier, W. M. Philbrick, P. Dann, J.-P. Zhang, J. Roume, A.-L. Delezoide, and C. Silve Absence of Functional Type 1 Parathyroid Hormone (PTH)/PTH-Related Protein Receptors in Humans Is Associated with Abnormal Breast Development and Tooth Impaction J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1788 - 1794. [Abstract] [Full Text] |
||||
![]() |
M. Minagawa, T. Watanabe, Y. Kohno, H. Mochizuki, G. N. Hendy, D. Goltzman, J. H. White, and T. Yasuda Analysis of the P3 Promoter of the Human Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene in Pseudohypoparathyroidism Type 1b J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1394 - 1397. [Abstract] [Full Text] |
||||
![]() |
G. J. Strewler The Physiology of Parathyroid Hormone-Related Protein N. Engl. J. Med., January 20, 2000; 342(3): 177 - 185. [Full Text] [PDF] |
||||
![]() |
D. Thomas, A Sunters, A Gentry, and A. Grigoriadis Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene J. Cell Sci., January 2, 2000; 113(3): 439 - 450. [Abstract] [PDF] |
||||
![]() |
J. Van Wyk Insulin-Like Growth Factors and Skeletal Growth: Possibilities for Therapeutic Interventions J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4349 - 4354. [Full Text] |
||||
![]() |
B. D. Gaylinn, V. I. DeAlmeida, C. E. Lyons Jr., K. C. Wu, K. E. Mayo, and M. O. Thorner The Mutant Growth Hormone-Releasing Hormone (GHRH) Receptor of the Little Mouse Does Not Bind GHRH Endocrinology, November 1, 1999; 140(11): 5066 - 5074. [Abstract] [Full Text] |
||||
![]() |
M. Mannstadt, H. Juppner, and T. J. Gardella Receptors for PTH and PTHrP: their biological importance and functional properties Am J Physiol Renal Physiol, November 1, 1999; 277(5): F665 - F675. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schipani, C. Langman, J. Hunzelman, M. Le Merrer, K. Y. Loke, M. J. Dillon, C. Silve, and H. Jüppner A Novel Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mutation in Jansen's Metaphyseal Chondrodysplasia J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3052 - 3057. [Abstract] [Full Text] |
||||
![]() |
D. A. Rubin, P. Hellman, L. I. Zon, C. J. Lobb, C. Bergwitz, and H. Juppner A G Protein-coupled Receptor from Zebrafish Is Activated by Human Parathyroid Hormone and Not by Human or Teleost Parathyroid Hormone-related Peptide. IMPLICATIONS FOR THE EVOLUTIONARY CONSERVATION OF CALCIUM-REGULATING PEPTIDE HORMONES J. Biol. Chem., August 13, 1999; 274(33): 23035 - 23042. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Nissenson Editorial: Parathyroid Hormone (PTH)/PTHrP Receptor Mutations in Human Chondrodysplasia Endocrinology, December 1, 1998; 139(12): 4753 - 4755. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |